Shelagh Glaser - 05 Sep 2025 Form 4 Insider Report for SYNOPSYS INC (SNPS)

Role
CFO
Signature
By: POA Pursuant Liz Ramirez For: Shelagh Glaser
Issuer symbol
SNPS
Transactions as of
05 Sep 2025
Net transactions value
-$949,598
Form type
4
Filing time
09 Sep 2025, 10:52:45 UTC
Previous filing
03 Sep 2025
Next filing
09 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glaser Shelagh CFO 675 ALMANOR AVENUE, SUNNYVALE By: POA Pursuant Liz Ramirez For: Shelagh Glaser 09 Sep 2025 0001865504

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNPS Common Stock Options Exercise $909,420 +2,612 +17% $348.17 17,929 05 Sep 2025 Direct
transaction SNPS Common Stock Sale $1,592,719 -2,612 -15% $609.77 15,317 05 Sep 2025 Direct
transaction SNPS Common Stock Options Exercise $369,691 +1,043 +6.8% $354.45 16,360 05 Sep 2025 Direct
transaction SNPS Common Stock Sale $635,990 -1,043 -6.4% $609.77 15,317 05 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPS Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,612 -17% $0.000000 13,061 05 Sep 2025 Common Stock 2,612 $348.17 Direct F1, F2
transaction SNPS Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,043 -14% $0.000000 6,409 05 Sep 2025 Common Stock 1,043 $354.45 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2025.
F2 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.